Finally, as a demonstration of the ability of TEPA to reduce intracellular copper levels in cancer cells, we observed a robust reduction in MT1X expression, a metallothionine used as a surrogate measure of intracellular levels of copper, by real-time PCR (Fig. 5f). This evidence concerns the gene MT1X and cancer.